genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2012
Glaucoma
Industry News
Dompé Acquires Remaining 51% of Anabasis for Lead NGF Ophthalmology Candidate
News
Altacor to Evaluate Proximagen Candidate in Glaucoma
Genome Editing
Oxford BioMedica and Mayo Clinic Partner to Develop Gene Therapy for Glaucoma
Industry News
Santen Starts Acquisition Bid for 50.55% Stake in Ophthalmic Drugs Firm Novagali
Genome Editing
FKD Therapies Acquires Exclusive License to Merck & Co.’s Gene Therapy Portfolio
Industry News
Amakem Raises €18M to Take Glaucoma Candidate Through Phase II Trials
Drug Discovery
Allergan Licenses Molecular Partners’ Phase II Eye Disease Protein Therapeutic for $45M
Industry News
Merck & Co. to Pick Up Inspire Pharmaceuticals for $430M
News
Sucampo Pays RTU $3M to Add New Territories to Ocular Drug License
Industry News
Aerie Raises $30M to Progress Glaucoma Drug into Phase III
1
...
3
4
5
6
Page 4 of 6
Scroll Up
Scroll Up
